Opening The Door For Cell Therapy In Solid Tumors

 
• By Daniel Chancellor

The next frontier for cell therapy is solid tumors – and of the many attempts to move from liquid to solid tumors, tumor infiltrating lymphocytes and other CAR-T constructs are some of the most promising. 

Immune response
Several groups shared research at ASCO for new CAR-T designs in well-defined subgroups of patients with solid tumors that have failed previous conventional therapies. • Source: Shutterstock

More from Clinical Trials

More from R&D